Apogem Capital LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Apogem Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $237,414 - $405,653	-24,103 Reduced 38.95%	37,784 $548,000
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $148,161 - $274,170	18,157 Added 41.52%	61,887 $609,000
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $145,230 - $220,049	12,967 Added 42.15%	43,730 $645,000
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $132,214 - $195,541	10,697 Added 53.31%	30,763 $407,000
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $107,895 - $154,433	6,306 Added 45.83%	20,066 $350,000
Q2 2021 Aug 16, 2021	BUY	$23.12 - $29.91 $318,131 - $411,561	13,760 New	13,760 $330,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.